InsidersTradesSigma
Explore the complete record of transactions filed by Ross Andrew L., Director. Director active across 1 companies, notably iSpecimen Inc.. Aggregated, 4 reports have been logged. Total volume traded: €1k. The latest transaction was filed on 17 June 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations
Andrew L. Ross is a Director of iSpecimen Inc. In this role, he participates in the governance of the company and strategic decision-making. iSpecimen Inc. specializes in the collection and distribution of biological samples. Andrew brings valuable expertise in leadership and strategy.